These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 11950912

  • 1. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
    Shukuwa T, Katayama I, Koji T.
    Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
    [Abstract] [Full Text] [Related]

  • 2. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X, Hazarika P, Zhang C, Talpur R, Duvic M.
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [Abstract] [Full Text] [Related]

  • 3. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.
    J Immunol; 1998 Jun 01; 160(11):5669-75. PubMed ID: 9605174
    [Abstract] [Full Text] [Related]

  • 4. [The relationship between Fas/FasL and proliferating cell nuclear antigen expression and malignant degree in human melanoma].
    Wang YC, Tan Y.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):965-8. PubMed ID: 18756968
    [Abstract] [Full Text] [Related]

  • 5. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC.
    Oncol Rep; 2003 Apr 08; 10(1):57-63. PubMed ID: 12469145
    [Abstract] [Full Text] [Related]

  • 6. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
    Yakirevich E, Maroun L, Cohen O, Izhak OB, Rennert G, Resnick MB.
    J Pathol; 2000 Oct 08; 192(2):166-73. PubMed ID: 11004692
    [Abstract] [Full Text] [Related]

  • 7. FAS, FAS ligand, tumor infiltrating lymphocytes, and macrophages in malignant melanoma: an immunohistochemical study.
    Bozdogan N, Bozdogan O, Pak I, Atasoy P.
    Int J Dermatol; 2010 Jul 08; 49(7):761-7. PubMed ID: 20618494
    [Abstract] [Full Text] [Related]

  • 8. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-gamma: involvement of Fas-mediated apoptosis in acute renal rejection.
    Akasaka Y, Ishikawa Y, Kato S, Ishii T, Masuda T, Fujita K, Yamada T, Kawamura S.
    Mod Pathol; 1998 Nov 08; 11(11):1107-14. PubMed ID: 9831209
    [Abstract] [Full Text] [Related]

  • 9. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K, Komuta K, Hashimoto S, Matsuzaki S, Kanematsu T, Koji T.
    Clin Cancer Res; 2000 Sep 08; 6(9):3560-4. PubMed ID: 10999744
    [Abstract] [Full Text] [Related]

  • 10. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G.
    J Immunol; 1998 Aug 01; 161(3):1220-30. PubMed ID: 9686582
    [Abstract] [Full Text] [Related]

  • 11. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ, Ku JK, Kim MY, Kang H, Cho SH, Kim HO, Park YM.
    Br J Dermatol; 2006 Mar 01; 154(3):419-25. PubMed ID: 16445769
    [Abstract] [Full Text] [Related]

  • 12. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC, Barnetson RS, Halliday GM.
    Br J Dermatol; 2004 Jul 01; 151(1):42-9. PubMed ID: 15270871
    [Abstract] [Full Text] [Related]

  • 13. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct 01; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T, Isse K, Shibata F, Aburatani I, Tsuneyama K, Sabit H, Harada K, Miyazaki K, Nakanuma Y.
    Hepatology; 2000 Oct 01; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [Abstract] [Full Text] [Related]

  • 15. Fas/Fas ligand system and apoptosis induction in testicular carcinoma.
    Schmelz HU, Abend M, Kraft K, Hauck EW, Weidner W, Van Beuningen D, Sparwasser C.
    Cancer; 2002 Jul 01; 95(1):73-81. PubMed ID: 12115319
    [Abstract] [Full Text] [Related]

  • 16. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 01; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 17. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
    Hamzaoui A, Ammar J, Graïri H, Hamzaoui K.
    Mediators Inflamm; 2003 Aug 01; 12(4):209-14. PubMed ID: 14514471
    [Abstract] [Full Text] [Related]

  • 18. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
    Nagao M, Nakajima Y, Hisanaga M, Kayagaki N, Kanehiro H, Aomatsu Y, Ko S, Yagita H, Yamada T, Okumura K, Nakano H.
    Hepatology; 1999 Aug 01; 30(2):413-21. PubMed ID: 10421649
    [Abstract] [Full Text] [Related]

  • 19. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis.
    Sugiura T, Murakawa Y, Nagai A, Kondo M, Kobayashi S.
    Arthritis Rheum; 1999 Feb 01; 42(2):291-8. PubMed ID: 10025923
    [Abstract] [Full Text] [Related]

  • 20. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.
    Mita A, Hashikura Y, Tagawa Y, Nakayama J, Kawakubo M, Miyagawa S.
    Am J Gastroenterol; 2005 Nov 01; 100(11):2551-9. PubMed ID: 16279913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.